08048036315
Rebopag 50 mg Good Quality Tablet to UK - London | Phoenix Exim | Trusted Exporter

1. General Information

Rebopag 50 mg Tablet is an oral medicine containing eltrombopag. It belongs to a class of medicines called thrombopoietin receptor agonists (TPO-RAs). It works by stimulating the thrombopoietin receptor and encouraging the bone marrow to produce more platelets.

Eltrombopag is prescribed for selected patients with conditions such as persistent or chronic immune thrombocytopenia (ITP) and severe aplastic anemia. It has also been used for thrombocytopenia associated with chronic hepatitis C in specific treatment settings.

2. Product Information

  • Product: Rebopag 50 mg Tablet
  • Active ingredient: Eltrombopag
  • Strength: 50 mg
  • Dosage form: Tablet
  • Drug class: Thrombopoietin receptor agonist
  • Route: Oral
  • Primary therapeutic area: Hematology
  • Manufacturer/exporter information: Verify the specific product packaging and manufacturer details before commercial use.

Eltrombopag tablets are available in several strengths, including 12.5 mg, 25 mg, 50 mg and 75 mg.

3. Uses of Rebopag 50 mg

Rebopag may be prescribed for:

  • Persistent or chronic immune thrombocytopenia (ITP) when previous treatments have not provided an adequate response.
  • Severe aplastic anemia, including use with standard immunosuppressive therapy in appropriate patients.
  • Certain cases of chronic hepatitis C-associated thrombocytopenia, where increasing platelet counts is necessary to support interferon-based treatment.

It should only be used for an appropriate diagnosed condition and under the supervision of a qualified healthcare professional.

4. Benefits of Rebopag 50 mg

The potential benefits of eltrombopag include:

  • Helps stimulate platelet production.
  • Can increase platelet counts in appropriate patients.
  • May reduce the risk associated with very low platelet counts.
  • Can provide a treatment option for selected patients with persistent or chronic ITP.
  • May be used as part of treatment for severe aplastic anemia according to the prescribed treatment protocol.

The objective is generally to achieve a clinically appropriate platelet count rather than simply producing the highest possible platelet count.

5. Side Effects

Like other prescription medicines, eltrombopag can cause side effects. Important potential risks include:

  • Liver toxicity or increased liver enzymes
  • Blood clots and thromboembolic complications
  • Headache
  • Nausea
  • Diarrhea
  • Fatigue
  • Anemia
  • Fever
  • Cough

Eltrombopag can cause serious liver problems, so liver-function monitoring is important during treatment.

Seek urgent medical attention for symptoms that could indicate a serious reaction, such as severe abdominal pain, yellowing of the skin or eyes, unusual swelling, chest pain, difficulty breathing, or symptoms suggestive of a blood clot.

6. Common Side Effects

Reported adverse reactions can vary according to the condition being treated. Frequently reported reactions across indications include:

  • Nausea
  • Headache
  • Fatigue
  • Diarrhea
  • Cough
  • Fever
  • Anemia
  • Increased ALT/liver enzyme levels

Not every patient experiences these effects, and the frequency can differ depending on the indication and treatment regimen.

7. How to Use Rebopag 50 mg

Take Rebopag exactly as prescribed by your doctor.

Eltrombopag tablets are generally taken orally once daily, but the exact dose depends on the patient's condition, age, ethnicity, liver status, platelet response, and other medicines.

For administration, eltrombopag should generally be taken:

  • Without food, or with a meal containing 50 mg or less of calcium.
  • At least 2 hours before or 4 hours after medicines or products containing polyvalent cations, such as calcium-containing products, certain antacids, iron, magnesium, zinc or mineral supplements.

Do not change the dose or stop treatment without medical advice. Regular platelet and liver-function monitoring may be required.

8. How This Medicine Works

Eltrombopag works as a thrombopoietin receptor agonist.

It activates the thrombopoietin receptor on bone-marrow cells involved in platelet production. This stimulates the development and production of megakaryocytes and ultimately increases platelet production.

Therefore, Rebopag does not directly replace platelets; instead, it encourages the body to produce more of them.

9. Safety Advice

Important precautions include:

  • Use only under prescription and medical supervision.
  • Regularly monitor platelet counts as directed.
  • Liver-function testing may be required before and during treatment.
  • Inform your doctor about existing liver disease.
  • Tell your doctor about all medicines, vitamins, antacids and mineral supplements you take.
  • Avoid taking calcium-rich foods or polyvalent-cation-containing products too close to the tablet.
  • Report unusual bleeding or clot-related symptoms promptly.
  • Inform your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.
  • Do not exceed the prescribed dose.
  • Do not use the medicine for conditions for which it has not been prescribed.

Eltrombopag carries important warnings concerning hepatotoxicity and thrombotic/thromboembolic complications. Patients with chronic hepatitis C require particular attention because of the risk of hepatic decompensation in certain treatment combinations.

10. FAQs

Q1. What is Rebopag 50 mg Tablet?

Rebopag 50 mg is an eltrombopag-containing tablet used to increase platelet production in certain conditions involving low platelet counts.

Q2. What is the active ingredient?

The assumed active ingredient is eltrombopag 50 mg. Always verify the composition printed on the specific product packaging.

Q3. What is Rebopag 50 mg used for?

It may be used for selected cases of chronic/persistent ITP and severe aplastic anemia, and in certain chronic hepatitis C treatment settings.

Q4. Is Rebopag a platelet medicine?

It is not a platelet transfusion. It stimulates the body's platelet-producing process through the thrombopoietin receptor.

Q5. Can Rebopag be taken with food?

Eltrombopag should generally be taken without food or with a meal low in calcium. Calcium-containing products can reduce absorption.

Q6. Does Rebopag require a prescription?

Yes. Eltrombopag is a prescription medicine and should be used under appropriate medical supervision.

Q7. Does everyone taking Rebopag need blood tests?

Monitoring requirements depend on the indication and patient, but platelet counts and liver function are commonly monitored during treatment.

Q8. Can I stop Rebopag suddenly?

Do not stop or change treatment without speaking with your prescribing healthcare professional.

Q9. Can Rebopag cause liver problems?

Yes. Eltrombopag can cause hepatotoxicity, making liver-function monitoring important.

Q10. Can Rebopag increase the risk of blood clots?

Yes. Thrombotic and thromboembolic complications have been reported, so platelet counts and clinical status should be monitored.

11. Substitute for Rebopag 50 mg

Potential alternatives depend entirely on the underlying condition and patient-specific factors. Other eltrombopag brands or generic products containing the same active ingredient may be pharmaceutical alternatives, while other thrombopoietin-receptor agonists such as romiplostim or avatrombopag may be considered in particular clinical circumstances.

These medicines are not automatically interchangeable. The appropriate substitute should be selected by a healthcare professional based on the diagnosis, platelet count, liver function, previous treatment response, age, and local treatment guidelines.

12. SEO Keywords

Product Keywords

  • Rebopag 50 mg Tablet
  • Rebopag 50 mg tablets
  • Rebopag 50 mg Eltrombopag
  • Eltrombopag 50 mg Tablet
  • Eltrombopag 50 mg tablets supplier
  • Eltrombopag 50 mg manufacturer
  • Eltrombopag tablets exporter
  • Eltrombopag medicine exporter India
  • Eltrombopag 50 mg pharmaceutical supplier
  • Eltrombopag 50 mg wholesale supplier

B2B / Export Keywords

  • Rebopag 50 mg exporter from India
  • Rebopag 50 mg supplier from India
  • Eltrombopag 50 mg exporter from Nagpur India
  • Eltrombopag 50 mg wholesale supplier India
  • Eltrombopag medicine export from India
  • pharmaceutical exporter Nagpur India
  • trusted medicine exporter from India
  • bulk Eltrombopag 50 mg supplier
  • Eltrombopag 50 mg international supplier
  • pharmaceutical products exporter India

Country-Specific SEO Keywords

  • Rebopag 50 mg supplier USA
  • Rebopag 50 mg supplier UK
  • Rebopag 50 mg supplier Australia
  • Rebopag 50 mg supplier Canada
  • Rebopag 50 mg supplier Singapore
  • Rebopag 50 mg supplier South Korea
  • Rebopag 50 mg supplier UAE
  • Eltrombopag 50 mg exporter to USA
  • Eltrombopag 50 mg exporter to UK
  • Eltrombopag 50 mg exporter to Australia
  • Eltrombopag 50 mg exporter to Canada
  • Eltrombopag 50 mg exporter to Singapore
  • Eltrombopag 50 mg exporter to South Korea
  • Eltrombopag 50 mg exporter to UAE

Phoenix Exim SEO Keywords

  • Phoenix Exim Rebopag 50 mg supplier
  • Phoenix Exim Eltrombopag 50 mg exporter
  • Phoenix Exim medicine exporter Nagpur
  • Phoenix Exim pharmaceutical exporter India
  • Phoenix Exim Eltrombopag supplier
  • Phoenix Exim oncology and hematology medicine supplier
  • Phoenix Exim international pharmaceutical supplier
Aug 13th, 2026 3:49 PM

Keywords